🔴 Moleculin Biotech is trading 5.34% down today despite a broader biotech sector rally

Moleculin Biotech is trading at $0.58 (-5.34%) as the stock declines on no clear company-specific news or announcements.

• Trading volume reached 373.38K, remaining significantly below the daily average of 1.3 million shares.
• The stock diverged from the broader biotech sector, which rallied following Moderna’s positive Phase 3 cancer-vaccine results.
• Recent catalysts, including the August 14 earnings report and MIRACLE-trial updates, were already known to the market.